|
Cycloplegia - Wikipedia, the free encyclopedia
Cycloplegia is paralysis of the ciliary muscle of the eye, resulting in a loss of accommodation. The iris is the heavily pigmented colored part of the eye. It has a contractile diaphragm in front of ...
en.wikipedia.org/wiki/Cycloplegia |
|
From Wikipedia, the free encyclopedia ... Jump to: navigation, search ... Ophthalmologicals: mydriatics and cycloplegics (S01F)
|
||
|
Cycloplegics defined on the Free Online Medical Dictionary. Medical terminology definitions including drugs, abbreviations, equipment, devices, and more from almost all medical specialties. Online-Medical-Dictionary.org ... a free online medical dictionary search engine for definitions of medical terminology,
|
||
|
Dilating drops (Mydriatics and Cycloplegics) - Dilating drops generally have the dual function of mydriasis and cycloplegia, the latter being caused by paralysis of the ciliary muscle and so paralysis of accommodation.1 They are used both for the examination of the fundus (more short acting agents), for cycloplegic ...
|
||
|
Excerpt: "Mydriatics and cycloplegics both dilate the pupil. In addition, cycloplegics cause paralysis of accommodation (patient unable to see near objects, eg, printed words). They are commonly used drugs in ophthalmology, singly and in combination.
|
||
|
Mydriatics and cycloplegics are used in the treatment of anterior uveitis, usually as an adjunct to corticosteriods (section 11.4.1). ...
|
||
|
Cyclopentolate 1% (action up to 24 hours) or atropine (action up to 7 days) are preferable for producing cycloplegia for refraction in young children. ...
|
||
|
Mydriatics and cycloplegics should be used with some care when patients exhibit narrow angles. Complications can occur, but are not common, and can be dealt with should an emergency occur. Side effects will be blurred vision and photobia, and driving immediately after dilation or cycloplegia is not recommended.
|
||
|
The only plausible mechanism is an increase in uveoscleral outflow that can occur with cycloplegics. There was never any clinical evidence of pupillary ...
|
||
|
Atropine Sulfate Ophthalmic Solution, 1% ... Compares to ISOPTO® Atropine Solution by Alcon Laboratories, Inc. ... NDC# 6131430301; 6131430302...
|